CD274 and breast carcinoma: However, following PD-L1 knockout, both CSC and non-CSC populations showed similar levels of cleaved caspase 3 (Supplementary Fig. 1d), suggesting that the enhanced PD-L1 expression in CSCs contributes to CSC resistance to PBMC-mediated killing in vitro in our breast cancer model system.